# Effects of Pentoxiphylline on Left Ventricular (LV) Systolic Function Indices and Circulating Biomarkers in Patients With Chronic Congestive Heart Failure (CHF)

> **NCT01337349** · NA · WITHDRAWN · sponsor: **Henry Ford Health System**

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DRUG:** Placebo
- **DRUG:** Pentoxifylline

## Key facts

- **NCT ID:** NCT01337349
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-07
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Did not enroll
- **Last updated:** 2022-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01337349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01337349, "Effects of Pentoxiphylline on Left Ventricular (LV) Systolic Function Indices and Circulating Biomarkers in Patients With Chronic Congestive Heart Failure (CHF)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01337349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*